CA
NZ
UK
AU
IND
US
…
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and ActivHeal brand names. The company provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Advanced Medical Solutions Group plc develops, manufactures and sells advanced wound care and surgical products, including haemostats, tissue adhesives and wound dressings, serving hospitals and healthcare providers internationally. Long-term growth could be supported by ageing populations, rising chronic wounds, international expansion and product innovation, while manufacturing and regulatory capabilities may help sustain demand.
Investors should monitor regulatory and reimbursement pressure, competitive and pricing risks in wound-care and surgical markets, and execution risk from international expansion or supply-chain disruptions.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 17.78M | 9.82M | 21.16M | 25.91M | 21.98M |
| Minority interest | - | -0.05M | 0.00M | - | - |
| Net income | 9.95M | 7.09M | 15.89M | 20.41M | 17.48M |
| Selling general administrative | - | 69.03M | 50.67M | 47.38M | 36.97M |
| Selling and marketing expenses | - | 2.35M | 1.52M | 1.63M | 1.48M |
| Gross profit | 108.78M | 82.77M | 70.14M | 73.42M | 61.07M |
| Reconciled depreciation | - | 16.30M | 10.79M | 8.84M | 8.85M |
| Ebit | 21.99M | 13.38M | 20.61M | 24.89M | 23.00M |
| Ebitda | 43.39M | 29.68M | 31.40M | 35.42M | 31.93M |
| Depreciation and amortization | 21.40M | 16.30M | 10.79M | 10.54M | 8.93M |
| Operating income | 21.99M | 10.45M | 18.88M | 24.89M | 23.00M |
| Other operating expenses | 206.94M | 167.07M | 107.33M | 99.44M | 85.60M |
| Interest expense | 5.09M | 3.56M | 0.38M | 0.67M | 1.10M |
| Tax provision | - | 2.68M | 5.27M | 5.50M | 4.50M |
| Interest income | - | 1.29M | 2.47M | 1.69M | 0.08M |
| Net interest income | - | -2.26M | 2.09M | 1.02M | -1.01M |
| Income tax expense | 7.69M | 2.68M | 5.27M | 5.50M | 4.50M |
| Total revenue | 228.94M | 177.52M | 126.21M | 124.33M | 108.60M |
| Total operating expenses | 86.79M | 81.40M | 51.26M | 48.53M | 38.07M |
| Cost of revenue | 120.16M | 84.90M | 56.07M | 50.91M | 47.53M |
| Total other income expense net | -4.21M | -0.63M | 2.27M | 1.02M | -1.01M |
| Net income from continuing ops | - | 7.14M | 15.89M | 20.41M | 17.48M |
| Net income applicable to common shares | - | - | - | 20.41M | 17.48M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 394.77M | 389.00M | 289.17M | 281.09M | 249.51M |
| Intangible assets | - | 97.41M | 55.86M | 48.37M | 40.96M |
| Other current assets | 1.21M | 0.30M | 3.83M | 21.74M | 22.71M |
| Total liab | 134.67M | 147.48M | 44.97M | 44.47M | 36.83M |
| Total stockholder equity | 258.79M | 240.78M | 244.20M | 236.62M | 212.68M |
| Deferred long term liab | - | - | - | - | 10.48M |
| Other current liab | 4.29M | -1.05M | 11.86M | 0.95M | 0.90M |
| Common stock | 10.98M | 10.89M | 10.87M | 10.84M | 10.80M |
| Capital stock | - | 10.89M | 10.87M | 10.84M | 10.80M |
| Retained earnings | 184.64M | 180.47M | 178.53M | 167.42M | 151.35M |
| Other liab | - | - | - | 13.10M | 11.12M |
| Good will | - | 116.88M | 80.44M | 70.86M | 66.03M |
| Other assets | - | 0.00M | - | 0.94M | 10.58M |
| Cash | 18.02M | 17.04M | 60.16M | 82.26M | 72.97M |
| Total current liabilities | 49.95M | 44.33M | 21.58M | 22.68M | 17.01M |
| Current deferred revenue | - | - | -1.16M | - | - |
| Net debt | 63.51M | 72.61M | -51.02M | -72.51M | -63.10M |
| Short term debt | 14.70M | 11.60M | 2.33M | 1.06M | 1.15M |
| Short long term debt | - | 5.42M | 0.00M | - | - |
| Short long term debt total | 81.52M | 89.65M | 9.14M | 9.75M | 9.86M |
| Other stockholder equity | 37.84M | 32.18M | 32.13M | 58.36M | 50.52M |
| Property plant equipment | - | - | - | 29.02M | 27.44M |
| Total current assets | 139.37M | 126.28M | 122.32M | 131.91M | 114.97M |
| Net tangible assets | - | - | - | 117.39M | 116.16M |
| Net receivables | 50.09M | 53.68M | 22.29M | 21.55M | 22.71M |
| Long term debt | - | 67.43M | 0.00M | - | - |
| Inventory | 70.05M | 55.26M | 36.05M | 27.91M | 19.30M |
| Accounts payable | 30.95M | 33.78M | 6.23M | 20.67M | 14.96M |
| Accumulated other comprehensive income | 25.33M | 17.23M | 22.68M | - | - |
| Non currrent assets other | - | 0.50M | 0.59M | 0.94M | 0.10M |
| Non current assets total | 255.40M | 262.72M | 166.85M | 149.18M | 134.54M |
| Capital lease obligations | - | 13.71M | 9.14M | 9.75M | 9.86M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -67.15M | -20.27M | -11.88M | -6.33M |
| Change to liabilities | - | - | - | 1.71M | 2.10M |
| Total cashflows from investing activities | -13.54M | -67.15M | -20.27M | -11.88M | -6.33M |
| Net borrowings | - | 17.26M | -0.48M | -1.63M | -1.28M |
| Total cash from financing activities | -14.92M | 5.48M | -13.62M | -6.32M | -5.11M |
| Net income | 9.95M | 7.09M | 15.89M | 24.89M | 23.00M |
| Change in cash | 0.98M | -43.12M | -22.10M | 9.30M | 19.14M |
| Begin period cash flow | 17.04M | 60.16M | 82.26M | 72.97M | 53.83M |
| End period cash flow | 18.02M | 17.04M | 60.16M | 82.26M | 72.97M |
| Total cash from operating activities | 28.75M | 19.49M | 12.35M | 26.88M | 31.02M |
| Issuance of capital stock | - | 0.01M | 0.18M | 0.66M | 1.09M |
| Depreciation | 21.40M | 16.30M | 10.79M | 8.84M | 8.85M |
| Other cashflows from investing activities | - | 1.23M | -3.79M | 0.82M | 0.08M |
| Dividends paid | 5.79M | 5.20M | 4.78M | 4.34M | 3.85M |
| Change to inventory | -13.27M | -0.00M | -8.06M | -7.09M | 0.94M |
| Change to account receivables | 5.04M | -10.38M | -2.52M | -0.60M | -1.77M |
| Sale purchase of stock | - | 0.00M | -6.71M | -0.39M | -0.37M |
| Other cashflows from financing activities | -3.88M | -6.59M | -1.83M | -1.91M | -1.61M |
| Change to netincome | - | - | - | 3.60M | 3.42M |
| Capital expenditures | 7.36M | 4.06M | 9.85M | 9.96M | 6.46M |
| Change in working capital | -10.28M | -6.07M | -15.83M | -5.97M | 1.28M |
| Stock based compensation | - | 3.09M | 2.92M | 2.44M | 1.98M |
| Other non cash items | 7.68M | 2.16M | -1.42M | -3.32M | -4.08M |
| Free cash flow | 21.39M | 12.67M | 2.50M | 16.91M | 24.56M |
Sector: Healthcare Industry: Medical Instruments & Supplies
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AMS Advanced Medical Solutions Group plc |
1.00 0.35% |
283.00 | 40.60 | 16.84 | 1.92 | 1.66 | 2.16 | 11.16 |
| CTEC ConvaTec Group PLC |
-4.20 1.71% |
240.80 | 37.27 | 14.66 | 1.79 | 3.77 | 2.94 | 13.89 |
| TSTL Tristel |
- -% |
407.50 | 23.75 | 19.08 | 3.68 | 5.29 | 3.43 | 13.18 |
| SPEC Inspecs Group plc |
-3.00 3.33% |
87.00 | - | 16.16 | 0.43 | 0.95 | 0.62 | 7.94 |
| BVC Batm Advanced Communications Ltd |
-0.25 2.16% |
11.30 | - | 39.53 | 0.36 | 0.90 | 0.37 | 2.44 |
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and ActivHeal brand names. The company provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. Andrew Christopher Meredith BSc (Hons) | CEO & Exec. Director | 1967 |
| Mr. Edward Johnson ACA | CFO & Exec. Director | 1972 |
| Mr. Alan Richardson | Chief Operations Officer | NA |
| Ms. Cathy Tomlinson | Group HR Director | NA |
| Mr. Brian Dowd | Head of US Commercial Team | NA |
| Mr. Owen Bromley | Company Sec. | NA |
| Mr. Andrew Christopher Meredith BSc (Hons) | CEO & Executive Director | 1966 |
| Mr. Edward Johnson ACA | CFO, ESG Lead & Executive Director | 1972 |
| Mr. Michael Edward King | Investor Relations Manager | NA |
| Simon Swain | Head of Legal | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...